Purchase Order 36C25226P0108
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $29,090.18 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 10mg and 20mg tablets. The contract, which carries an ultimate completion date of February 3, 2026, was awarded on December 3, 2025, with no set-aside designation. Performance will be executed at Exelan's facility in Boca Raton, Florida. This delivery order falls under the GSA Federal Supply Schedule...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a delivery order valued at $4.77M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. This firm fixed-price contract, awarded on December 8, 2025, with an ultimate completion date of December 7, 2026, was issued without a set-aside designation, allowing full and open competition. The contract is performed in Boca Raton, Florida, where Exelan maintains its pharmaceutical manufacturing and...
- Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor, was awarded a $1 million firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 10 on December 15, 2025, for the supply of Lenalidomide/Revlimid doses. The contract carries an ultimate completion date of December 14, 2026, and will be performed at the company's facility in Boca Raton, Florida. No set-aside designation was applied to this...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order contract valued at $193,101.16 to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 20mg to support emergency pharmacy operations. The award, issued on November 13, 2025, is structured as a firm fixed-price delivery order with performance completion targeted for September 30, 2026. Exelan Pharmaceuticals will deliver the medication to a location in Boca Raton, Florida. This contract...
- Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor, was awarded a firm fixed-price purchase order valued at $2.0 million by Veterans Integrated Service Network 12 (VISN 12) on December 15, 2025, for the supply of Lenalidomide/Revlimid. The contract, which carries no set-aside designation and was awarded through open competitive procurement, will be performed at the awardee's Boca Raton facility with delivery to the VA facility in Danville,...
- Exelan Pharmaceuticals Inc., a pharmaceutical manufacturing and distribution company based in Boca Raton, Florida, was awarded a firm fixed-price delivery order by Veterans Integrated Service Network 20 (VISN 20) on November 3, 2025, for the supply of Lenalidomide. The contract ceiling value is $1.28M with an ultimate completion date of September 30, 2026. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation,...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 21, a civilian agency, to Exelan Pharmaceuticals Inc., a foreign-owned for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the supply of the drug Lenalidomide in 15mg and 25mg dosages, with a ceiling value of $36,464.61 and a completion date of November 23, 2025. The contract is not set aside and is awarded under Exelan's Federal Supply Schedule contract for...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded an emergency delivery order to Exelan Pharmaceuticals Inc. on August 27, 2025, for the procurement of Lenalidomide in 15mg and 2.5mg formulations. This firm fixed-price contract, valued at $10,397.48, was funded through fiscal year 2025 Defense and Overseas Contingency Operations (DEOB) appropriations and carries an ultimate completion date of September 30, 2025. The award was issued without a set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 awarded a $3.6M firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. The contract was awarded on December 1, 2025, with an ultimate completion date of September 30, 2026, and carries no set-aside designation. Performance will take place in Iowa City, Iowa. This delivery order falls under the GSA Schedule Pharmaceuticals and Drugs contract vehicle (FSS-61-IB), enabling the...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 21, a civilian agency, to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the emergency procurement of 15mg and 2.5mg Lenalidomide capsules, with a ceiling value of $20,432.37 and a completion date of December 31, 2025. Exelan Pharmaceuticals is a key supplier of pharmaceutical products to various federal healthcare...
The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $3 million firm fixed-price purchase order to Exelan Pharmaceuticals Inc. for the supply of generic lenalidomide. The contract, awarded on December 15, 2025, with an ultimate completion date of December 14, 2026, will be performed in Boca Raton, Florida. No set-aside designation was used in this competitive procurement, allowing Exelan to compete openly for the award. Lenalidomide is an immunomodulatory medication commonly used in the treatment of multiple myeloma and certain lymphomas, making this procurement critical to VA pharmaceutical supply chains serving veteran populations. Exelan Pharmaceuticals is a foreign-owned pharmaceutical manufacturer and distributor specializing in generic drug repackaging and distribution for federal healthcare agencies. The company holds extensive experience with the VA and Department of Defense through multiple indefinite delivery contracts and federal supply schedule vehicles, with contract values historically ranging from tens of thousands to millions of dollars. Exelan's core service involves consolidating pharmaceutical products into patient-ready prescriptions and distribution packages for federal healthcare facilities, supporting the VA, DoD, Bureau of Prisons, and Indian Health Service through their respective pharmaceutical prime vendor programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0m | 12/11/25 |